Types of therapy | Anti-hypertensive classes | n (%) |
Monotherapy 85 (49.13%) | Diuretics | 29 (16.86%) |
Calcium Channel Blockers | 29 (16.28%) | |
Angiotensin-converting enzyme/Angiotensin II receptor blockers | 26 (15.12%) | |
Central Antihypertensive | 1 (1.58%) | |
Bitherapy 67 (38.95%) | Calcium Channel Blockers and Diuretics | 24 (13.95%) |
Angiotensin-converting enzyme/Angiotensin II receptor blockers and Diuretics | 36 (20.93%) | |
Calcium Channel Blockers and Angiotensin-converting enzyme/Angiotensin II receptor blockers | 5 (2.91%) | |
Calcium Channel Blockers and Central Antihypertensive | 1 (0.58%) | |
Calcium Channel Blockers and β-blocker | 1 (0.58%) | |
Tritherapy 21 (12.14%) | Calcium Channel Blockers, Angiotensin-converting enzyme/Angiotensin II receptor blockers and Diuretics | 21 (12.14%) |